Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hefei Yisheng Pharmaceutical is a Chinese pharmaceutical company specializing in the development and manufacturing of chemical drug preparations. Founded in 2003 and based in Hefei, Anhui Province, the company focuses on therapeutic areas including cardiovascular health, gastroenterology, and anti-infectives. Its product portfolio features several widely used generic medications such as amlodipine besylate, rabeprazole sodium, and levofloxacin. The company operates manufacturing facilities that are fully compliant with Chinese Good Manufacturing Practice (GMP) standards. Hefei Yisheng is recognized as a high-tech enterprise and primarily serves the domestic Chinese healthcare market through hospital and retail pharmacy channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hefei Yisheng Pharmaceutical.